GSK Warns Pharmacists Of Ziagen, Combivir Mix Up
This article was originally published in The Pink Sheet Daily
Executive Summary
FDA issues a MedWatch alert April 10 advising of misbranded bottles of the HIV drug Combivir containing Ziagen instead.
You may also be interested in...
FDA Will Exercise Enforcement Discretion On Pedigrees
The agency will require pedigrees to trace transactions back to the authorized distributor of record while a preliminary injunction is in effect.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.
Teva Says The Time Is Right For Two Big Immunology Biosimilar Launches
US market access senior VP Tom Rainey talks to Scrip about the upcoming launches of biosimilar versions of Humira and Stelara.